AnalyzeDirect

Kobylecki C, Langheinrich T, Hinz R, Vardy E, Brown G, Martino M, Haense C, Richardson A, Gerhard A, Anton-Rodriguez J, Snowden J, Neary D, Pontecorvo M, Herholz K. ¹⁸F-florbetapir positron emission tomography in patients with frontotemporal dementia and Alzheimer’s disease. J Nucl Med. February 2015.

Publication Date
February 2015

How Analyze was Used
“Grey and white matter object maps were created by convolving the normalized anatomical atlas with binary grey and white matter masks, and uptake. 7 values were extracted in ANALYZE 10.0. The average of all neocortical areas was presented as the mean cortical uptake value.”

Keywords
Alzheimer Disease
Amyloid
Diagnosis
Frontotemporal Dementia
Molecular Imaging
Neurology
Positron Emission Tomography (PET)

Author Affiliation(s)
Greater Manchester Neurosciences Centre, Eccles, Salford, UK. (CK, TL, AR, JS, DN)

University of Manchester, Manchester, UK. (RH, GB, AG, JAR, KH)

Newcastle University, Tyne and Wear, UK. (EV)

Unidad de Medicina y Cirugía Experimental, Madrid, Spain. (MM)

Hannover Medical School, Hannover, Germany. (CH)

Avid Radiopharmaceuticals, Philadelphia, PA, US. (MP)

ID# 1666

Tags: Alzheimer Disease, Amyloid, Diagnosis, Frontotemporal Dementia, Molecular Imaging, Neurology, Positron Emission Tomography (PET)